Skip to main content
Premium Trial:

Request an Annual Quote

Luminex Revenues Surge 17 Percent in Q3 as Loss Swings to Profit

NEW YORK (GenomeWeb News) — Luminex yesterday said third-quarter revenues increased 17 percent as the company swung to a profit.
Total receipts for the three months ended Sept. 30 increased to $12.5 million from $10.7 million year over year.
The majority of the company’s revenue came from sales of its Luminex systems, about a third came from consumables, and the rest was from royalties.
R&D spending in the quarter increased by more than half to $2.3 million from $1.5 million in the year-ago period.
Luminex this quarter posted a $111,000 profit compared to a net loss of $657,000 year over year.
Luminex said the income for the quarter includes $1.4 million in non-cash stock compensation expenses, of which about $560 thousand came from the adoption of new accounting standards.
The company had around $24.8 million in cash and equivalents and $11.2 million in short-term investments as of Sept. 30.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.